Skip to main content

Advertisement

Table 2 Cost-effectiveness of therapy as assessed by 38 prescribers during cycle A and cycle B

From: Drug use evaluation of cefepime in the first affiliated hospital of Bengbu medical college: a retrospective and prospective analysis

Cost-effective Number and percentage in cycle A Number and percentage in cycle B
Yes 30 (78.95%) 31 (81.58%)
No 5 (13.16%) 5 (13.16%)
Sometimes 3 (7.89%) 2 (5.26%)